Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has been recognized for its project in a next generation manufacturing facility for high viscosity pharmaceutical products, built in Shenzhen, China. The project ‘Shenzhen Hepalink Pingshan New Pre-filled Syringe Manufacturing Facility’ was completed 4 February 2025 covering 297,715 square feet with an annual capacity of 330 million units. It also achieved EU GMP Certification.

Learn More